{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:38:50Z","timestamp":1792543130570,"version":"4.5.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA260239"],"award-info":[{"award-number":["R01CA260239"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["4R01AG064250"],"award-info":[{"award-number":["4R01AG064250"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Dr. and Mrs. James Robert Spenser Family","award":["P30CA247796"],"award-info":[{"award-number":["P30CA247796"]}]},{"name":"Women\u2019s Global Health Institute (WGHI) & The Catherine Peachey Fund"},{"name":"National Science Foundation","award":["CHE-2404098"],"award-info":[{"award-number":["CHE-2404098"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genome Biol"],"DOI":"10.1186\/s13059-026-04212-w","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T09:25:01Z","timestamp":1784885101000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Profiling protein post-translational modifications in plasma-derived extracellular vesicles as fingerprints for breast cancer subtypes"],"prefix":"10.1186","volume":"27","author":[{"given":"Marco","family":"Hadisurya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hillary Andaluz","family":"Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Hsuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengting","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Sebastian","family":"Paez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachit","family":"Bisht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoti","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-Chi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhesam","family":"Mashaollahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Iliuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weizhou","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Andy","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"key":"4212_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3402\/jev.v4.27066","volume":"4","author":"M Y\u00e1\u00f1ez-M\u00f3","year":"2015","unstructured":"Y\u00e1\u00f1ez-M\u00f3 M, Siljander PRM, Andreu Z, BedinaZavec A, Borr\u00e0s FE, Buzas EI, et al. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles. 2015;4:1\u201360. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/10.3402\/jev.v4.27066.","journal-title":"J Extracell Vesicles"},{"key":"4212_CR2","doi-asserted-by":"publisher","first-page":"27522","DOI":"10.3402\/jev.v4.27522","volume":"4","author":"T An","year":"2015","unstructured":"An T, Qin S, Xu Y, Tang Y, Huang Y, Situ B, et al. Exosomes serve as tumour markers for personalized diagnostics owing to their important role in cancer metastasis. J Extracell Vesicles. 2015;4:27522. Available from: https:\/\/www.tandfonline.com\/doi\/full\/10.3402\/jev.v4.27522.","journal-title":"J Extracell Vesicles"},{"key":"4212_CR3","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1038\/nbt1252","volume":"24","author":"G Walsh","year":"2006","unstructured":"Walsh G, Jefferis R. Post-translational modifications in the context of therapeutic proteins. Nat Biotechnol. 2006;24:1241\u201352.","journal-title":"Nat Biotechnol"},{"key":"4212_CR4","doi-asserted-by":"crossref","unstructured":"Yang M, Li, Kong L, Huang S, He L, Liu P, et al. Inhibition of DPAGT1 suppresses HER2 shedding and trastuzumab resistance in human breast cancer. J Clin Invest. 2023;133. Available from: https:\/\/www.jci.org\/articles\/view\/164428.","DOI":"10.1172\/JCI164428"},{"key":"4212_CR5","doi-asserted-by":"publisher","first-page":"790","DOI":"10.2144\/000112201","volume":"40","author":"MR Larsen","year":"2006","unstructured":"Larsen MR, Trelle MB, Thingholm TE, Jensen ON. Analysis of posttranslational modifications of proteins by tandem mass spectrometry. Biotechniques. 2006;40:790\u20138. Available from: https:\/\/www.tandfonline.com\/doi\/full\/10.2144\/000112201.","journal-title":"Biotechniques"},{"key":"4212_CR6","doi-asserted-by":"publisher","first-page":"3308","DOI":"10.1021\/acs.jproteome.8b00459","volume":"17","author":"X Wu","year":"2018","unstructured":"Wu X, Li L, Iliuk A, Tao WA. Highly efficient phosphoproteome capture and analysis from urinary extracellular vesicles. J Proteome Res. 2018;17:3308\u201316.","journal-title":"J Proteome Res"},{"key":"4212_CR7","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1021\/acs.jproteome.0c00151","volume":"19","author":"A Iliuk","year":"2020","unstructured":"Iliuk A, Wu X, Li L, Sun J, Hadisurya M, Boris RS, et al. Plasma-derived extracellular vesicle phosphoproteomics through chemical affinity purification. J Proteome Res. 2020;19:2563\u201374. Available from: https:\/\/pubs.acs.org\/doi\/10.1021\/acs.jproteome.0c00151.","journal-title":"J Proteome Res"},{"key":"4212_CR8","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/s43856-023-00294-w","volume":"3","author":"M Hadisurya","year":"2023","unstructured":"Hadisurya M, Li L, Kuwaranancharoen K, Wu X, Lee Z, Alcalay RN, et al. Quantitative proteomics and phosphoproteomics of urinary extracellular vesicles define putative diagnostic biosignatures for Parkinson\u2019s disease. Commun Med. 2023;3:64. Available from: https:\/\/www.nature.com\/articles\/s43856-023-00294-w.","journal-title":"Commun Med"},{"key":"4212_CR9","doi-asserted-by":"publisher","unstructured":"Hadisurya M, Lee ZC, Luo Z, Zhang G, Ding Y, Zhang H, et al. Data-independent acquisition phosphoproteomics of urinary extracellular vesicles enables renal cell carcinoma grade differentiation. Mol Cell Proteomics. 2023:100536. https:\/\/doi.org\/10.1016\/j.pestbp.2022.105078.","DOI":"10.1016\/j.pestbp.2022.105078"},{"key":"4212_CR10","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/s41596-019-0260-5","volume":"15","author":"H Andaluz Aguilar","year":"2020","unstructured":"Andaluz Aguilar H, Iliuk AB, Chen I-H, Tao WA. Sequential phosphoproteomics and N-glycoproteomics of plasma-derived extracellular vesicles. Nat Protoc. 2020;15:161\u201380. https:\/\/doi.org\/10.1038\/s41596-019-0260-5.","journal-title":"Nat Protoc"},{"key":"4212_CR11","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1073\/pnas.1618088114","volume":"114","author":"IH Chen","year":"2017","unstructured":"Chen IH, Xue L, Hsu CC, Paez JSP, Pan L, Andaluz H, et al. Phosphoproteins in extracellular vesicles as candidate markers for breast cancer. Proc Natl Acad Sci. 2017;114:3175\u201380. Available from: https:\/\/pnas.org\/doi\/full\/10.1073\/pnas.1618088114.","journal-title":"Proc Natl Acad Sci"},{"key":"4212_CR12","doi-asserted-by":"publisher","first-page":"6307","DOI":"10.1021\/acs.analchem.8b01090","volume":"90","author":"IH Chen","year":"2018","unstructured":"Chen IH, Aguilar HA, PaezPaez JS, Wu X, Pan L, Wendt MK, et al. Analytical pipeline for discovery and verification of glycoproteins from plasma-derived extracellular vesicles as breast cancer biomarkers. Anal Chem. 2018;90:6307\u201313. Available from: https:\/\/pubs.acs.org\/doi\/10.1021\/acs.analchem.8b01090.","journal-title":"Anal Chem"},{"key":"4212_CR13","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.soc.2017.08.005","volume":"27","author":"SM Fragomeni","year":"2018","unstructured":"Fragomeni SM, Sciallis A, Jeruss JS. Molecular subtypes and local-regional control of breast cancer. Surg Oncol Clin N Am. 2018;27:95\u2013120. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1055320717300807.","journal-title":"Surg Oncol Clin N Am"},{"key":"4212_CR14","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1111\/j.1524-4741.2009.00822.x","volume":"15","author":"CA Parise","year":"2009","unstructured":"Parise CA, Bauer KR, Brown MM, Caggiano V. Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999\u20132004. Breast J. 2009;15:593\u2013602.","journal-title":"Breast J"},{"key":"4212_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1177\/117822341000400004","volume":"4","author":"K Subik","year":"2010","unstructured":"Subik K, Lee JF, Baxter L, Strzepek T, Costello D, Crowley P, et al. The expression patterns of ER, PR, HER2, CK5\/6, EGFR, KI-67 and AR by immunohistochemical analysis in breast cancer cell lines. Breast Cancer Basic Clin Res. 2010;4:35\u201341.","journal-title":"Breast Cancer Basic Clin Res"},{"key":"4212_CR16","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1093\/annonc\/mdt303","volume":"24","author":"A Goldhirsch","year":"2013","unstructured":"Goldhirsch A, Winer EP, Coates AS, Gelber RD, Piccart-Gebhart M, Th\u00fcrlimann B, et al. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2013. Ann Oncol. 2013;24:2206\u201323. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419369649.","journal-title":"Ann Oncol"},{"key":"4212_CR17","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1093\/jnci\/djp082","volume":"101","author":"MCU Cheang","year":"2009","unstructured":"Cheang MCU, Chia SK, Voduc D, Gao D, Leung S, Snider J, et al. Ki67 Index, HER2 status, and prognosis of patients with luminal B breast cancer. JNCI J Natl Cancer Inst. 2009;101:736\u201350. Available from: https:\/\/academic.oup.com\/jnci\/article-lookup\/doi\/10.1093\/jnci\/djp082.","journal-title":"JNCI J Natl Cancer Inst"},{"key":"4212_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fonc.2018.00308","volume":"8","author":"TJ Ballinger","year":"2018","unstructured":"Ballinger TJ, Meier JB, Jansen VM. Current landscape of targeted therapies for hormone-receptor positive, HER2 negative metastatic breast cancer. Front Oncol. 2018;8:1\u201311. Available from: https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2018.00308\/full.","journal-title":"Front Oncol"},{"key":"4212_CR19","doi-asserted-by":"publisher","first-page":"48","DOI":"10.7812\/TPP\/14-241","volume":"19","author":"BI Bodai","year":"2015","unstructured":"Bodai BI, Tuso P. Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations. Perm J. 2015;19:48\u201379. Available from: http:\/\/www.thepermanentejournal.org\/doi\/10.7812\/TPP\/14-241.","journal-title":"Perm J"},{"key":"4212_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-019-0570-8","author":"S Rontogianni","year":"2019","unstructured":"Rontogianni S, Synadaki E, Li B, Liefaard MC, Lips EH, Wesseling J, et al. Proteomic profiling of extracellular vesicles allows for human breast cancer subtyping. Commun Biol. 2019. https:\/\/doi.org\/10.1038\/s42003-019-0570-8.","journal-title":"Commun Biol"},{"key":"4212_CR21","doi-asserted-by":"crossref","unstructured":"Grimes M, Hall B, Foltz L, Levy T, Rikova K, Gaiser J, et al. Integration of protein phosphorylation, acetylation, and methylation data sets to outline lung cancer signaling networks. Sci Signal. 2018;11. Available from: https:\/\/www.science.org\/doi\/10.1126\/scisignal.aaq1087.","DOI":"10.1126\/scisignal.aaq1087"},{"key":"4212_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms10259","volume":"7","author":"S Tyanova","year":"2016","unstructured":"Tyanova S, Albrechtsen R, Kronqvist P, Cox J, Mann M, Geiger T. Proteomic maps of breast cancer subtypes. Nat Commun. 2016;7:1\u201311. https:\/\/doi.org\/10.1038\/ncomms10259.","journal-title":"Nat Commun"},{"key":"4212_CR23","doi-asserted-by":"publisher","first-page":"D1694","DOI":"10.1093\/nar\/gkad1007","volume":"52","author":"SV Chitti","year":"2024","unstructured":"Chitti SV, Gummadi S, Kang T, Shahi S, Marzan AL, Nedeva C, et al. Vesiclepedia 2024: an extracellular vesicles and extracellular particles repository. Nucleic Acids Res. 2024;52:D1694-8. Available from: https:\/\/academic.oup.com\/nar\/article\/52\/D1\/D1694\/7416396.","journal-title":"Nucleic Acids Res"},{"key":"4212_CR24","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.jmb.2015.09.019","volume":"428","author":"S Keerthikumar","year":"2016","unstructured":"Keerthikumar S, Chisanga D, Ariyaratne D, Al Saffar H, Anand S, Zhao K, et al. ExoCarta: a web-based compendium of exosomal cargo. J Mol Biol. 2016;428:688\u201392.","journal-title":"J Mol Biol"},{"key":"4212_CR25","doi-asserted-by":"publisher","first-page":"5449","DOI":"10.18632\/oncotarget.3216","volume":"6","author":"R Sabatier","year":"2015","unstructured":"Sabatier R, Finetti P, Mamessier E, Adelaide J, Chaffanet M, Ali HR, et al. Prognostic and predictive value of PDL1 expression in breast cancer. Oncotarget. 2015;6:5449\u201364. Available from: https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.3216.","journal-title":"Oncotarget"},{"key":"4212_CR26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10549-014-2988-5","volume":"146","author":"S Muenst","year":"2014","unstructured":"Muenst S, Schaerli AR, Gao F, D\u00e4ster S, Trella E, Droeser RA, et al. Expression of programmed death ligand 1 (PD-L1) is associated with poor prognosis in human breast cancer. Breast Cancer Res Treat. 2014;146:15\u201324. Available from: http:\/\/link.springer.com\/10.1007\/s10549-014-2988-5.","journal-title":"Breast Cancer Res Treat"},{"key":"4212_CR27","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1158\/2326-6066.CIR-13-0127","volume":"2","author":"EA Mittendorf","year":"2014","unstructured":"Mittendorf EA, Philips AV, Meric-Bernstam F, Qiao N, Wu Y, Harrington S, et al. PD-L1 expression in triple-negative breast cancer. Cancer Immunol Res. 2014;2:361\u201370. Available from: https:\/\/aacrjournals.org\/cancerimmunolres\/article\/2\/4\/361\/467294\/PD-L1-Expression-in-Triple-Negative-Breast.","journal-title":"Cancer Immunol Res"},{"key":"4212_CR28","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1016\/j.molonc.2015.05.009","volume":"9","author":"M Mazel","year":"2015","unstructured":"Mazel M, Jacot W, Pantel K, Bartkowiak K, Topart D, Cayrefourcq L, et al. Frequent expression of PD-L1 on circulating breast cancer cells. Mol Oncol. 2015;9:1773\u201382. Available from: https:\/\/febs.onlinelibrary.wiley.com\/doi\/10.1016\/j.molonc.2015.05.009.","journal-title":"Mol Oncol"},{"key":"4212_CR29","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ccell.2018.01.009","volume":"33","author":"CW Li","year":"2018","unstructured":"Li CW, Lim SO, Chung EM, Kim YS, Park AH, Yao J, et al. Eradication of triple-negative breast cancer cells by targeting glycosylated PD-L1. Cancer Cell. 2018;33:187-201.e10. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535610818300096.","journal-title":"Cancer Cell"},{"key":"4212_CR30","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/PPO.0b013e3181d24fc1","volume":"16","author":"ML Burness","year":"2010","unstructured":"Burness ML, Grushko TA, Olopade OI. Epidermal growth factor receptor in triple-negative and basal-like breast cancer. Cancer J. 2010;16:23\u201332. Available from: https:\/\/journals.lww.com\/00130404-201002000-00005.","journal-title":"Cancer J"},{"key":"4212_CR31","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/cncr.22381","volume":"109","author":"EA Rakha","year":"2007","unstructured":"Rakha EA, El-Sayed ME, Green AR, Lee AHS, Robertson JF, Ellis IO. Prognostic markers in triple-negative breast cancer. Cancer. 2007;109:25\u201332. Available from: https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.1002\/cncr.22381.","journal-title":"Cancer"},{"key":"4212_CR32","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s10549-012-2289-9","volume":"136","author":"H Masuda","year":"2012","unstructured":"Masuda H, Zhang D, Bartholomeusz C, Hara H, Hortobagyi GN, Ueno NT. Role of epidermal growth factor receptor in breast cancer. Breast Cancer Res Treat. 2012;136:331\u201345. Available from: http:\/\/www.nature.com\/articles\/sigtrans201642.","journal-title":"Breast Cancer Res Treat"},{"key":"4212_CR33","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1186\/1471-2407-14-958","volume":"14","author":"K Doberstein","year":"2014","unstructured":"Doberstein K, Milde-Langosch K, Bretz NP, Schirmer U, Harari A, Witzel I, et al. L1CAM is expressed in triple-negative breast cancers and is inversely correlated with Androgen receptor. BMC Cancer. 2014;14:958. Available from: https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-14-958.","journal-title":"BMC Cancer"},{"key":"4212_CR34","first-page":"275","volume":"17","author":"JM Giltnane","year":"2014","unstructured":"Giltnane JM, Balko JM. Rationale for targeting the Ras\/MAPK pathway in triple-negative breast cancer. Discov Med. 2014;17:275\u201383. Available from: http:\/\/europepmc.org\/abstract\/MED\/24882719.","journal-title":"Discov Med"},{"key":"4212_CR35","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.clbc.2013.05.003","volume":"13","author":"I Shabo","year":"2013","unstructured":"Shabo I, Olsson H, St\u00e5l O, Svanvik J. Breast cancer expression of DAP12 is associated with skeletal and liver metastases and poor survival. Clin Breast Cancer. 2013;13:371\u20137. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820913001109.","journal-title":"Clin Breast Cancer"},{"key":"4212_CR36","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41523-017-0009-7","volume":"3","author":"JJ Bower","year":"2017","unstructured":"Bower JJ, Vance LD, Psioda M, Smith-Roe SL, Simpson DA, Ibrahim JG, et al. Patterns of cell cycle checkpoint deregulation associated with intrinsic molecular subtypes of human breast cancer cells. npj Breast Cancer. 2017;3:9. https:\/\/doi.org\/10.1038\/s41523-017-0009-7.","journal-title":"npj Breast Cancer"},{"key":"4212_CR37","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.3390\/cells9102167","volume":"9","author":"B Humphries","year":"2020","unstructured":"Humphries B, Wang Z, Yang C. Rho GTPases: big players in breast cancer initiation, metastasis and therapeutic responses. Cells. 2020;9:2167. Available from: https:\/\/www.mdpi.com\/2073-4409\/9\/10\/2167.","journal-title":"Cells"},{"key":"4212_CR38","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.cellsig.2018.04.008","volume":"48","author":"M Zar\u00e0","year":"2018","unstructured":"Zar\u00e0 M, Canobbio I, Visconte C, Canino J, Torti M, Guidetti GF. Molecular mechanisms of platelet activation and aggregation induced by breast cancer cells. Cell Signal. 2018;48:45\u201353. https:\/\/doi.org\/10.1016\/j.cellsig.2018.04.008.","journal-title":"Cell Signal"},{"key":"4212_CR39","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.3390\/cancers15133390","volume":"15","author":"P Lei","year":"2023","unstructured":"Lei P, Wang W, Sheldon M, Sun Y, Yao F, Ma L. Role of glucose metabolic reprogramming in breast cancer progression and drug resistance. Cancers (Basel). 2023;15:3390. Available from: https:\/\/www.mdpi.com\/2072-6694\/15\/13\/3390.","journal-title":"Cancers (Basel)"},{"key":"4212_CR40","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1593\/neo.101590","volume":"13","author":"Z Davison","year":"2011","unstructured":"Davison Z, de Blacqui\u00e8re GE, Westley BR, May FEB. Insulin-like growth factor-dependent proliferation and survival of triple-negative breast cancer cells: implications for therapy. Neoplasia. 2011;13:504\u201315. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558611800424.","journal-title":"Neoplasia"},{"key":"4212_CR41","doi-asserted-by":"publisher","first-page":"713","DOI":"10.3390\/cancers13040713","volume":"13","author":"V Zolota","year":"2021","unstructured":"Zolota V, Tzelepi V, Piperigkou Z, Kourea H, Papakonstantinou E, Argentou MI, et al. Epigenetic alterations in triple-negative breast cancer\u2014the critical role of extracellular matrix. Cancers (Basel). 2021;13:713. Available from: https:\/\/www.mdpi.com\/2072-6694\/13\/4\/713.","journal-title":"Cancers (Basel)"},{"key":"4212_CR42","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13578-024-01249-x","volume":"14","author":"ML Marshall","year":"2024","unstructured":"Marshall ML, Fung KYC, Jans DA, Wagstaff KM. Tumour-specific phosphorylation of serine 419 drives alpha-enolase (ENO1) nuclear export in triple negative breast cancer progression. Cell Biosci. 2024;14:74. Available from: https:\/\/cellandbioscience.biomedcentral.com\/articles\/10.1186\/s13578-024-01249-x.","journal-title":"Cell Biosci"},{"key":"4212_CR43","doi-asserted-by":"publisher","first-page":"781","DOI":"10.3892\/ijo.2017.4085","volume":"51","author":"S Obayashi","year":"2017","unstructured":"Obayashi S, Horiguchi J, Higuchi T, Katayama A, Handa T, Altan B, et al. Stathmin1 expression is associated with aggressive phenotypes and cancer stem cell marker expression in breast cancer patients. Int J Oncol. 2017;51:781\u201390. Available from: https:\/\/www.spandidos-publications.com\/10.3892\/ijo.2017.4085.","journal-title":"Int J Oncol"},{"key":"4212_CR44","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1080\/00313020600559975","volume":"38","author":"N Kwaepila","year":"2006","unstructured":"Kwaepila N, Burns G, Leong ASY. Immunohistological localisation of human FAT1 (hFAT) protein in 326 breast cancers. Does this adhesion molecule have a role in pathogenesis? Pathology. 2006;38:125\u201331. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302516339708.","journal-title":"Pathology"},{"key":"4212_CR45","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.yexmp.2015.12.012","volume":"100","author":"L Wang","year":"2016","unstructured":"Wang L, Lyu S, Wang S, Shen H, Niu F, Liu X, et al. Loss of FAT1 during the progression from DCIS to IDC and predict poor clinical outcome in breast cancer. Exp Mol Pathol. 2016;100:177\u201383. https:\/\/doi.org\/10.1016\/j.yexmp.2015.12.012.","journal-title":"Exp Mol Pathol"},{"key":"4212_CR46","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3390\/cancers15020362","volume":"15","author":"M Lodi","year":"2023","unstructured":"Lodi M, Voilquin L, Alpy F, Moli\u00e8re S, Reix N, Mathelin C, et al. STARD3: a new biomarker in HER2-positive breast cancer. Cancers (Basel). 2023;15:362. Available from: https:\/\/www.mdpi.com\/2072-6694\/15\/2\/362.","journal-title":"Cancers (Basel)"},{"key":"4212_CR47","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1002\/gcc.22091","volume":"52","author":"C Eifert","year":"2013","unstructured":"Eifert C, Wang X, Kokabee L, Kourtidis A, Jain R, Gerdes MJ, et al. A novel isoform of the B cell tyrosine kinase BTK protects breast cancer cells from apoptosis. Genes, Chromosom Cancer. 2013;52:961\u201375. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/gcc.22091.","journal-title":"Genes, Chromosom Cancer"},{"key":"4212_CR48","doi-asserted-by":"publisher","first-page":"13075","DOI":"10.1073\/pnas.1004594107","volume":"107","author":"LA Honigberg","year":"2010","unstructured":"Honigberg LA, Smith AM, Sirisawad M, Verner E, Loury D, Chang B, et al. The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy. Proc Natl Acad Sci. 2010;107:13075\u201380. Available from: https:\/\/pnas.org\/doi\/full\/10.1073\/pnas.1004594107.","journal-title":"Proc Natl Acad Sci"},{"key":"4212_CR49","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1517\/13543784.2012.685650","volume":"21","author":"T Robak","year":"2012","unstructured":"Robak T, Robak E. Tyrosine kinase inhibitors as potential drugs for B-cell lymphoid malignancies and autoimmune disorders. Expert Opin Investig Drugs. 2012;21:921\u201347. Available from: https:\/\/www.tandfonline.com\/doi\/full\/10.1517\/13543784.2012.685650.","journal-title":"Expert Opin Investig Drugs"},{"key":"4212_CR50","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nchembio.481","volume":"7","author":"JA Di Paolo","year":"2011","unstructured":"Di Paolo JA, Huang T, Balazs M, Barbosa J, Barck KH, Bravo BJ, et al. Specific Btk inhibition suppresses B cell\u2013 and myeloid cell\u2013mediated arthritis. Nat Chem Biol. 2011;7:41\u201350. Available from: https:\/\/www.nature.com\/articles\/nchembio.481.","journal-title":"Nat Chem Biol"},{"key":"4212_CR51","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1158\/1535-7163.MCT-15-0813","volume":"15","author":"X Wang","year":"2016","unstructured":"Wang X, Wong J, Sevinsky CJ, Kokabee L, Khan F, Sun Y, et al. Bruton\u2019s tyrosine kinase inhibitors prevent therapeutic escape in breast cancer cells. Mol Cancer Ther. 2016;15:2198\u2013208. Available from: https:\/\/aacrjournals.org\/mct\/article\/15\/9\/2198\/92102\/Bruton-s-Tyrosine-Kinase-Inhibitors-Prevent.","journal-title":"Mol Cancer Ther"},{"key":"4212_CR52","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s13058-023-01676-7","volume":"25","author":"C Zheng","year":"2023","unstructured":"Zheng C, Xu X, Wu M, Xue L, Zhu J, Xia H, et al. Neutrophils in triple-negative breast cancer: an underestimated player with increasingly recognized importance. Breast Cancer Res. 2023;25:88. Available from: https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/s13058-023-01676-7.","journal-title":"Breast Cancer Res"},{"key":"4212_CR53","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41523-025-00721-2","volume":"11","author":"NAM Bakker","year":"2025","unstructured":"Bakker NAM, Garner H, van Dyk E, Champanhet E, Klaver C, Duijst M, et al. Triple-negative breast cancer modifies the systemic immune landscape and alters neutrophil functionality. npj Breast Cancer. 2025;11:5. https:\/\/doi.org\/10.1038\/s41523-025-00721-2.","journal-title":"npj Breast Cancer"},{"key":"4212_CR54","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature18003","volume":"534","author":"P Mertins","year":"2016","unstructured":"Mertins P, Mani DR, Ruggles KV, Gillette MA, Clauser KR, Wang P, et al. Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 2016;534:55\u201362. Available from: https:\/\/www.nature.com\/articles\/nature18003.","journal-title":"Nature"},{"key":"4212_CR55","doi-asserted-by":"crossref","unstructured":"Courcelles M, Fr\u00e9min C, Voisin L, Lemieux S, Meloche S, Thibault P. Phosphoproteome dynamics reveal novel ERK1\/2 MAP kinase substrates with broad spectrum of functions. Mol Syst Biol. 2013;9. Available from: https:\/\/www.embopress.org\/doi\/10.1038\/msb.2013.25.","DOI":"10.1038\/msb.2013.25"},{"key":"4212_CR56","doi-asserted-by":"publisher","first-page":"e83680","DOI":"10.1371\/journal.pone.0083680","volume":"8","author":"L Issman","year":"2013","unstructured":"Issman L, Brenner B, Talmon Y, Aharon A. Cryogenic transmission electron microscopy nanostructural study of shed microparticles. Frischknecht F, editor. PLoS One. 2013;8:e83680. Available from: https:\/\/dx.plos.org\/10.1371\/journal.pone.0083680.","journal-title":"PLoS One"},{"key":"4212_CR57","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1021\/pr700658q","volume":"7","author":"T Masuda","year":"2008","unstructured":"Masuda T, Tomita M, Ishihama Y. Phase transfer surfactant-aided trypsin digestion for membrane proteome analysis. J Proteome Res. 2008;7:731\u201340.","journal-title":"J Proteome Res"},{"key":"4212_CR58","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1074\/mcp.M110.000091","volume":"9","author":"AB Iliuk","year":"2010","unstructured":"Iliuk AB, Martin VA, Alicie BM, Geahlen RL, Tao WA. In-depth analyses of kinase-dependent tyrosine phosphoproteomes based on metal ion-functionalized soluble nanopolymers. Mol Cell Proteomics. 2010;9:2162\u201372.","journal-title":"Mol Cell Proteomics"},{"key":"4212_CR59","doi-asserted-by":"crossref","unstructured":"Tyanova S, Cox J. Perseus: a bioinformatics platform for integrative analysis of proteomics data in cancer research. Methods Mol Biol. 2018:133\u201348. Available from: http:\/\/link.springer.com\/10.1007\/978-1-4939-7493-1_7.","DOI":"10.1007\/978-1-4939-7493-1_7"},{"key":"4212_CR60","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1093\/bioinformatics\/btq054","volume":"26","author":"B MacLean","year":"2010","unstructured":"MacLean B, Tomazela DM, Shulman N, Chambers M, Finney GL, Frewen B, et al. Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics. 2010;26:966\u20138.","journal-title":"Bioinformatics"},{"key":"4212_CR61","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nmeth.3901","volume":"13","author":"S Tyanova","year":"2016","unstructured":"Tyanova S, Temu T, Sinitcyn P, Carlson A, Hein MY, Geiger T, et al. The perseus computational platform for comprehensive analysis of (prote)omics data. Nat Methods. 2016;13:731\u201340. Available from: https:\/\/www.nature.com\/articles\/nmeth.3901.","journal-title":"Nat Methods"},{"key":"4212_CR62","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12920-019-0514-7","volume":"12","author":"SJ Park","year":"2019","unstructured":"Park SJ, Yoon BH, Kim SK, Kim SY. GENT2: an updated gene expression database for normal and tumor tissues. BMC Med Genomics. 2019;12:101. Available from: https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-019-0514-7.","journal-title":"BMC Med Genomics"},{"key":"4212_CR63","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. Omi A J Integr Biol. 2012;16:284\u20137. Available from: http:\/\/www.liebertpub.com\/doi\/10.1089\/omi.2011.0118.","journal-title":"Omi A J Integr Biol"},{"key":"4212_CR64","doi-asserted-by":"crossref","unstructured":"Wright MN, Ziegler A. ranger\u202f: a fast implementation of random forests for high dimensional data in C++ and R. J Stat Softw. 2017;77. Available from: http:\/\/www.jstatsoft.org\/v77\/i01\/.","DOI":"10.18637\/jss.v077.i01"},{"key":"4212_CR65","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. 2022. https:\/\/www.R-project.org\/."},{"key":"4212_CR66","doi-asserted-by":"crossref","unstructured":"McKinney W. Data structures for statistical computing in Python. 2010. p. 56\u201361. Available from: https:\/\/conference.scipy.org\/proceedings\/scipy2010\/mckinney.html.","DOI":"10.25080\/Majora-92bf1922-00a"},{"key":"4212_CR67","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/s41586-020-2649-2","volume":"585","author":"CR Harris","year":"2020","unstructured":"Harris CR, Millman KJ, van der Walt SJ, Gommers R, Virtanen P, Cournapeau D, et al. Array programming with NumPy. Nature. 2020;585:357\u201362. Available from: https:\/\/www.nature.com\/articles\/s41586-020-2649-2.","journal-title":"Nature"},{"key":"4212_CR68","doi-asserted-by":"publisher","first-page":"638","DOI":"10.21105\/joss.00638","volume":"3","author":"S Raschka","year":"2018","unstructured":"Raschka S. MLxtend: providing machine learning and data science utilities and extensions to Python\u2019s scientific computing stack. J Open Source Softw. 2018;3:638. Available from: http:\/\/joss.theoj.org\/papers\/10.21105\/joss.00638.","journal-title":"J Open Source Softw"},{"key":"4212_CR69","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1109\/MCSE.2007.55","volume":"9","author":"JD Hunter","year":"2007","unstructured":"Hunter JD. Matplotlib: a 2D graphics environment. Comput Sci Eng. 2007;9:90\u20135. Available from: http:\/\/ieeexplore.ieee.org\/document\/4160265\/.","journal-title":"Comput Sci Eng"},{"key":"4212_CR70","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.21105\/joss.03021","volume":"6","author":"M Waskom","year":"2021","unstructured":"Waskom M. seaborn: statistical data visualization. J Open Source Softw. 2021;6:3021. Available from: https:\/\/joss.theoj.org\/papers\/10.21105\/joss.03021.","journal-title":"J Open Source Softw"},{"key":"4212_CR71","doi-asserted-by":"publisher","first-page":"D1107","DOI":"10.1093\/nar\/gkw1080","volume":"45","author":"S Okuda","year":"2017","unstructured":"Okuda S, Watanabe Y, Moriya Y, Kawano S, Yamamoto T, Matsumoto M, et al. jPOSTrepo: an international standard data repository for proteomes. Nucleic Acids Res. 2017;45:D1107-11. Available from: https:\/\/academic.oup.com\/nar\/article-lookup\/doi\/10.1093\/nar\/gkw1080.","journal-title":"Nucleic Acids Res"},{"key":"4212_CR72","unstructured":"Hadisurya M, Aguilar HA, Chen IH, Xu M, Paez JS, Bisht R, et al. Profiling protein post-translational modifications in plasma-derived extracellular vesicles as fingerprints for breast cancer subtypes. jPOSTrepo; 2024. Available from: https:\/\/repository.jpostdb.org\/preview\/161878879467242b62ae7a7."},{"key":"4212_CR73","doi-asserted-by":"publisher","DOI":"10.6069\/js1s-k435","author":"M Hadisurya","year":"2024","unstructured":"Hadisurya M, Aguilar HA, Chen IH, Xu M, Paez JS, Bisht R, et al. Profiling protein post-translational modifications in plasma-derived extracellular vesicles as fingerprints for breast cancer subtypes. Panorama Public. 2024. https:\/\/doi.org\/10.6069\/js1s-k435.","journal-title":"Panorama Public"},{"key":"4212_CR74","doi-asserted-by":"crossref","unstructured":"Hadisurya M, Aguilar HA, Chen IH, Xu M, Paez JS, Bisht R, et al. Profiling protein post-translational modifications in plasma-derived extracellular vesicles as fingerprints for breast cancer subtypes. GitFront; 2024. Available from: https:\/\/gitfront.io\/r\/rvchit\/DQCiPixbEQTt\/Tao-Lab-Breast-Cancer\/.","DOI":"10.21203\/rs.3.rs-7294729\/v1"}],"container-title":["Genome Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13059-026-04212-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13059-026-04212-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13059-026-04212-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:04:49Z","timestamp":1792541089000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13059-026-04212-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4212"],"URL":"https:\/\/doi.org\/10.1186\/s13059-026-04212-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7294729\/v1","asserted-by":"object"}]},"ISSN":["1474-760X"],"issn-type":[{"value":"1474-760X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"4 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Iowa University Institutional Review Board (IRB: UI IRB #201003791) approved the use of human plasma samples. The study design and conduct complied with all relevant regulations regarding the use of human study participants and was conducted in accordance with the criteria set by the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"A.I. and W.A.T. are the co-founders of Tymora Analytical Operations, which commercialized the PolyMAC kit used in parts of the described protocol.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"321"}}